Skip to search boxSkip to navigationSkip to main content

Human visceral leishmaniasis prevalence by different diagnostic methods in latin america: A systematic review and meta-analysis

  • Estefanía Gutiérrez-Ocampo
    ,
  • Rhuvi Villamizar-Peña
    ,
  • Isabella Cortes-Bonilla
    ,
  • Luisa M. García-Zuluaga
    ,
  • Yeimer Holguin-Rivera
    ,
  • Harrison D. Ospina-Arzuaga
  • Zoonóticas y tropicales de Risaralda
    ,
  • Fundacion Universitaria Autonoma de las Américas
    ,
  • Universidad Científica del Sur
    ,
  • Universidad Nacional Hermilio Valdizán
    ,
  • Universidad Nacional Autónoma de Honduras
    ,
  • Instituto de Investigaciones Biomédicas IDB/Incubadora Venezolana de la Ciencia
Research Output:
Contribution to journal
Review article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 199-208 (10 pages)

Journal (Volume, Issue Number)

Infezioni in Medicina (Volume 29, Issue 2)

Publication milestones

  • Published - 2021

Publication status

Published - 2021

ISSN

1124-9390

Publication IDs

  • Scopus: 85107425681
  • PubMed: 34061784

Abstract

Visceral leishmaniasis is a neglected zoonotic disease that affects animals and humans in different tropical and subtropical regions and even beyond, with variable prevalence among infected hosts. To date, there have been no systematic reviews on human visceral leishma-niasis prevalence in Latin America. We therefore performed a systematic literature review with meta-analy-sis, using six databases to assess prevalence of visceral leishmaniasis in human patients in Latin American countries. Observational studies were included but analyzed separately. We performed a random-effects model meta-analysis to calculate the pooled prevalence and 95% confidence interval (95%CI). In all, 10,435 articles were retrieved for the time frame (1950-2019). After ini-tial screening, 120 articles were selected for full-text as-sessment, 97 being finally included for qualitative and quantitative analyses. Overall, VL pooled prevalence was estimated at 38.8% (95% CI 33.8-43.8%), derived from 97 studies, including 44,986 individuals. Many aspects of the transmission dynamics of Leishmania and the exact burden of this parasitosis on public health re-main largely unknown. Although the elimination of zoonotic VL in the Americas appears an unrealistic goal, additional efforts need to be put in place to achieve bet-ter diagnosis, treatment, and prevention of VL.

Publication metrics

Metrics

Scopus
Citations

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well